Life SciencesCompliance evidence produced while the work happens.

Validated environments where a change needs evidence before it ships.

A scientist and a quality manager examining sample vials at a laboratory bench
Grey: a regulatory submission today. Lime: the step we take the wait out of. Proportions illustrative.
~350slides migrated into structured dataOffline Investor Relations App for a Global Pharmaceutical Company

What is changing in Life Sciences

The pressures we hear from leadership teams in this sector, and the ones the work below answers.

  • Validation needs proof

    GxP and quality rules require evidence of how each process actually ran.

  • Long, costly cycles

    A delay in trials or submissions is counted in months and millions.

  • Many reporting audiences

    Investors, ESG frameworks and regulators each want a different view of the same data.

  • Data locked in documents

    Lab, finance and regulatory records live in PDFs and spreadsheets.

How we help in Life Sciences

The capabilities behind our work here. Open one to see what you get, how to start and the result it moved.

The stack most of our clients already own. We build inside it properly (solution-aware deployments, environment strategy and ALM), rather than leaving a sprawl of personal flows behind.

Ways to start in Life Sciences

Fixed-scope first steps we have run against exactly this kind of problem.

  • Start here

    AI Readiness Assessment

    Three weeks to separate the processes where AI changes the economics from the ones where it is an expensive way to run a rule.

    Duration
    3 weeks
    What you keep
    You leave with a defensible position for the board, built or not.
  • Lab

    Emerging Tech Sprint

    Two weeks testing one emerging technology against one of your real processes, ending in a recommendation you can act on or drop.

    Duration
    2 weeks
    What you keep
    'Walk away' is a legitimate outcome and we will say it.

Bars drawn to scale: one block is one week.

Our view

Clinical data handling, regulatory submissions and R&D operations. Automation here carries a documentation burden that most industries do not have, and we plan for it from the start.

Bring us one process in Life Sciences. We will tell you what it would take.

Not a proposal: a straight read on whether it is worth changing, what it costs and where it usually goes wrong in this sector.

Talk to a partner